Accupac to manufacture Gain access to Pharmaceuticals MuGard Gain access to PHARMACEUTICALS.

Kaiser Family members Foundation. Kaiser Health News, an unbiased news service editorially, is an application of the Kaiser Family Foundation, a nonpartisan health care policy research business unaffiliated with Kaiser Permanente.. Accupac to manufacture Gain access to Pharmaceuticals’ MuGard Gain access to PHARMACEUTICALS, INC. has entered into an contract with a leading commercial manufacturer to produce its FDA-accepted MuGard for UNITED STATES distribution. One or more U.S. Market seeding research could begin as soon as Q4 2009, the ongoing company says.Regarding the the financing, Eric Bednarski of MVM Life Technology Christopher and Companions Gabrieli of Bessemer Venture Companions have joined the AccuVein board. Aquilo Partners, L.P., a life science investment bank, acted as the exclusive placement agent for the financing. We are impressed by AccuVein’s proprietary technology and industrial execution and so are excited to utilize the company to boost patient treatment by making vein lighting broadly available to patients and clinicians, stated Dr. Bednarski, partner at MVM. Christopher Gabrieli, partner at Bessemer, added, AccuVein has developed a unique, innovative item with potential in multiple markets. We look forward to working with Ron and the team as they continue to expand their global footprint. We have become fortunate to become partnering with proven traders that completely support our initiatives to continue to create vein illumination area of the industry standard of care, said Ron Goldman, AccuVein CEO, They obviously recognize the vast potential and upcoming medical imaging applications of our technology and intellectual home.